Company intelligence / Profile preview
Scienpharm
Shanghai, Shanghai, Chinascienpharm.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Shanghai Scienpharm Co., Ltd. (also known as Shanghai Boyue Biotechnology Co., Ltd.) is an innovative pharmaceutical company founded in 2010 and headquartered in Shanghai, China. The company specializes in the research, development, and industrialization of active pharmaceutical ingredients (APIs), complex formulations, and improved new drugs. Scienpharm operates an integrated value chain spanning from pharmaceutical CRO/CDMO technical services to large-scale API manufacturing and global sales. Its proprietary technology platforms focus on high-barrier APIs, complex formulations, and small molecule drug discovery, with a pipeline targeting oncology, nervous system diseases, and musculoskeletal disorders. Notably, the company has successfully licensed its generic version of eperisone (Eisai's Myonal) to Shanghai Shyndec Pharmaceutical for RMB 10.5 million.
- Therapeutic areas
- RheumatologyNephrologyOphthalmologyNeurologyOncology
- Modalities
- Small molecule
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Shanghai Shyndec Pharmaceutical Co., Ltd.Minsheng Pharmaceutical Co., Ltd.Anbison Lab
Beyond the preview
Go deeper on Scienpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scienpharm.